Gaucher Type 1 (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate

Gregory A. Grabowski, Tama Dinur, Shimon Gatt, Robert J. Desnick

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

A new acid β-glucosidase assay for the detection of heterozygotes for Gaucher Type 1 disease has been developed using isolated lymphocytes as enzyme source and a novel fluorescent natural substrate, NBD-glucosyl ceramide. The procedure for optimal heterozygote discrimination was established by systematic evaluation of the effect of various solubilization techniques, detergent concentrations, pH, enzyme sources and artificial vs. natural substrates. A pilot screening study indicated the feasible application of this assay for heterozygote detection in the high-risk Ashkenazi Jewish population.

Original languageEnglish
Pages (from-to)123-135
Number of pages13
JournalClinica Chimica Acta
Volume124
Issue number1
DOIs
StatePublished - 1 Sep 1982

Fingerprint

Dive into the research topics of 'Gaucher Type 1 (Ashkenazi) disease: a new method for heterozygote detection using a novel fluorescent natural substrate'. Together they form a unique fingerprint.

Cite this